… Dendritic cell (DC) vaccines induce specific immune responses that can selectively eliminate
target cells. In recent years, many studies have been conducted to explore DC vaccination …

… approaches that involve patient’s ex vivo-generated antigen presenting cells (APCs) such
as DC-based vaccines avoid the reliance on endogenous APCs and are nowadays one of the …

… vaccines based on dendritic cells in clinical practice. A deeper study of the biology of dendritic
cells, … the field of application of dendritic cell (DC) vaccines and improve the indicators of …

… In this study we developed a liposome-based vaccine containing … target dendritic cells (DC)
for activation of both innate (invariant natural killer T-cells [iNKT]) and adaptive (CD8 + T-cells…

… As an important form of immunotherapy, dendritic cell (DC)–based vaccines have demonstrated
the ability to induce an immune response, while clinical efficacy of DC vaccines remains …

… Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable
development over recent decades. However, this field is currently in a state of flux toward niche-…

… CD8 T cell responses. There are two major hurdles for the success of DC-based vaccines:
tumor-… limitation of the commonly used monocyte-derived dendritic cells (MoDCs). Due to their …

… Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to
… The functional limitations of ex vivo monocyte-derived dendritic cells (MoDCs) commonly …

… , and to-date, only dendritic cell-based therapy to receive FDA approval … of dendritic cell
vaccines, which will be examined in this review. We also highlight the promise of these vaccines …

… -based vaccination in the clinical practice for cancer treatment. Moreover, the recent advances
in our knowledge of DC tolerization described here clearly indicate DC-based vaccines …